Fukushima T - Search Results

1

[Improvement of bleeding tendency and normalized platelet count increment following splenectomy in a patient with refractory anemia].

Kawai Y, Fukushima T, Ookura K, Yoshio N, Yamauchi T, Nakayama T, Tohyama K, Wano Y, Tsutani H, Ueda T, Nakamura T. Kawai Y, et al. Among authors: fukushima t. Rinsho Ketsueki. 1997 Jun;38(6):532-8. Rinsho Ketsueki. 1997. PMID: 9248330 Japanese.

2

[Five cases of hematological disorders associated with acute myocardial infarction in thrombocytopenia].

Yoshida A, Uchida M, Fukushima T, Tanaka T, Matuyama F, Lee JD, Ueda T, Domae N, Nakamura T. Yoshida A, et al. Among authors: fukushima t. Rinsho Ketsueki. 1992 Apr;33(4):473-7. Rinsho Ketsueki. 1992. PMID: 1602611 Japanese.

3

[Blastic crisis of primary myelofibrosis associated with multiple myeloblastomas ].

Fukushima T, Uchida M, Iwasaki H, Kamiya K, Tanaka T, Yoshimura T, Sasaki K, Tsutani H, Wano Y, Takayama H, et al. Fukushima T, et al. Rinsho Ketsueki. 1990 Jan;31(1):95-9. Rinsho Ketsueki. 1990. PMID: 2313911 Japanese.

4

Pharmacokinetic and clinical pilot study of high-dose intermittent ubenimex treatment in patients with myelodysplastic syndrome.

Ueda T, Tohyama K, Wano Y, Tsutani H, Fukushima T, Iwasaki H, Urasaki Y, Gotoh N, Kimura S, Okumura E, et al. Ueda T, et al. Among authors: fukushima t. Anticancer Res. 1994 Sep-Oct;14(5B):2093-7. Anticancer Res. 1994. PMID: 7840505 Clinical Trial.

5

Action mechanism of idarubicin (4-demethoxydaunorubicin) as compared with daunorubicin in leukemic cells.

Fukushima T, Ueda T, Uchida M, Nakamura T. Fukushima T, et al. Int J Hematol. 1993 Apr;57(2):121-30. Int J Hematol. 1993. PMID: 8494991

6

Successful treatment of cytomegalovirus retinitis in a patient with malignant lymphoma: a case report and review of the literature.

Kawai Y, Kawai R, Nakayama T, Tanizawa A, Urasaki Y, Fukushima T, Yoshida A, Yamauchi T, Tsutani H, Wano Y, Akagi Y, Ueda T. Kawai Y, et al. Among authors: fukushima t. Int J Hematol. 1999 Jun;69(4):256-9. Int J Hematol. 1999. PMID: 10407583 Review.

7

Monitoring of intracellular 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in 1-beta-D-arabinofuranosylcytosine therapy at low and conventional doses.

Yamauchi T, Kawai Y, Kishi S, Goto N, Urasaki Y, Imamura S, Fukushima T, Yoshida A, Iwasaki H, Tsutani H, Masada M, Ueda T. Yamauchi T, et al. Among authors: fukushima t. Jpn J Cancer Res. 2001 May;92(5):546-53. doi: 10.1111/j.1349-7006.2001.tb01128.x. Jpn J Cancer Res. 2001. PMID: 11376564 Free PMC article.

8

Close correlation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N(4)-behenoyl-1-beta-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia.

Yamauchi T, Kawai Y, Goto N, Kishi S, Imamura S, Yoshida A, Urasaki Y, Fukushima T, Iwasaki H, Tsutani H, Masada M, Ueda T. Yamauchi T, et al. Among authors: fukushima t. Jpn J Cancer Res. 2001 Sep;92(9):975-82. doi: 10.1111/j.1349-7006.2001.tb01188.x. Jpn J Cancer Res. 2001. PMID: 11572766 Free PMC article.

9

Long-term follow-up of the clinical efficacy of chemotherapy for acute myeloid leukemia at a single institute.

Seo T, Fukushima T, Inoue H, Imamura S, Urasaki Y, Yoshida A, Kawai Y, Yamauchi T, Iwasaki H, Tsutani H, Nakamura T, Ueda T. Seo T, et al. Among authors: fukushima t. J Infect Chemother. 2001 Sep;7(3):156-62. doi: 10.1007/s101560100028. J Infect Chemother. 2001. PMID: 11810577

10

[Pharmacokinetics and action mechanism of anthracyclines].

Fukushima T, Ueda T, Nakamura T. Fukushima T, et al. Gan To Kagaku Ryoho. 1992 Apr;19(4):445-50. Gan To Kagaku Ryoho. 1992. PMID: 1558393 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,554 results

Search Page

Filters